HELX — Franklin Genomic Adv ETF

Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme o...

Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.

Industry

ETF

Exchange

AMEX

First trade date

2020-02-25

The interactive platform loads with JavaScript. Research tools are for informational purposes.